Theme

GLP-1 and obesity drug stocks

Companies that sell or are developing GLP-1 drugs and other medicines for obesity, like the ones sold as Ozempic, Wegovy, Mounjaro, and Zepbound. Trial results, FDA decisions, and prices drive the news.

Today
-1.8%
on average, 13 of 14 down
Average score
-0.6
Poor. All stocks average 3.9.

Delayed 15+ min, as of 8:46 PM ET. Live for Pro members.

Highest Quality Scores

  1. AMGNAmgenDevelops MariTide, a GLP-1 based obesity shot in Phase 3 trials.-1.04%11
  2. LLYEli LillySells Zepbound and Mounjaro, GLP-1 drugs for obesity and diabetes.-0.61%10
  3. HIMSHims & Hers HealthSells weight loss treatments, including GLP-1 drugs, through its app.-1.02%2
See all 14 ranked, live

Free for 24 hours. No account needed. Then keep going with a free account.

The other 11, by name

Open any stock for its score. Pro members see every stock ranked.

Drugs on sale 2

Drugs in trials 8

Telehealth sellers 1

  • LFMDLifeMDRuns a telehealth weight loss program built around GLP-1 drugs.-3.86%
Pro

Here is what Pro members see.

Every theme has a page like this for Pro members, GLP-⁠1 and obesity drug stocks included: each stock ranked live by its Quality Score, with the reason it belongs.

The AI chips theme page a Pro member sees: every AI chip stock ranked live by Quality Score, each with what it does, its part of the theme, its price, the day's move, and its next report
The same page for Pro members, on AI chipsEach stock's price, move, next report, and Quality Score, live, with what it does in the theme.
The scanner's filters on a phone with Theme set to AI chips, under the sort, the minimum Quality Score, and the sector, over company size, and the button that shows the 14 matching stocks
The theme in the scannerPick GLP-⁠1 and obesity drugs under Theme in the scanner's filters, then narrow it by score, size, or any other filter.
The New alert form on a phone watching a saved scan, AI chips at Excellent and up, for when a name enters it, sent by the bell on the site, a push notification, and email, with the Save alert button
An optional theme alertAn optional alert when a GLP-⁠1 and obesity drug stock reaches Excellent, by push, email, or the bell.
  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

What moved today

Today, as of 8:46 PM ET, GLP-1 and obesity drug stocks are down 1.8% on average, 13 of 14 down. MBX Biosciences (MBX) rose most, up 3.5%. Kailera Therapeutics (KLRA) fell most, down 5.8%.

What moves GLP-1 and obesity drug stocks

  • Trial results and FDA decisions
  • Prices, and whether Medicare and insurers pay
  • Prescription numbers each quarter

What's next

Earnings reports across GLP-1 and obesity drug stocks, the next 30 days

  • EarningsVKTXViking Therapeutics reports, after the close (estimated date)
  • EarningsLLYEli Lilly reports, before the open

What are GLP-1 and obesity drug stocks?

Companies that sell or are developing GLP-1 drugs and other medicines for obesity, like the ones sold as Ozempic, Wegovy, Mounjaro, and Zepbound. Trial results, FDA decisions, and prices drive the news.

How many GLP-1 and obesity drug stocks are there?

This list has 14, the ones among the stocks Breakaway scores where the theme is the main business. Device makers whose parts go into the pens, supplement sellers, and companies whose obesity program is a minor one.

Which GLP-1 and obesity drug stocks have the highest Quality Score?

As of 8:46 PM ET: Amgen (AMGN) 11, Eli Lilly (LLY) 10, and Hims & Hers Health (HIMS) 2. Each stock's own page shows its score and the reasons behind it.

How this list is made

It sells or is developing a GLP-1 drug or another obesity medicine, or sells GLP-1 prescriptions as a main line, and its annual report says so. Each company is checked against its own annual report, and the reason beside it says what it does in this theme. Last checked Oct 2 2026.

Drug developers' FDA dates are on the FDA calendar. More in healthcare stocks, or every theme.

Every one of the 14, ranked.

Real-time prices, each stock's Quality Score, the theme's score over 60 sessions, every date ahead, the filing behind each company, and optional alerts.

Free for 24 hours. No account needed. Then keep going with a free account.

Prices and scores on this page are delayed at least 15 minutes. Information, not advice.

GLP-1 And Obesity Drug Stocks List | Breakaway